ICD-10: M76.40

Tibial collateral bursitis, also known as Pellegrini-Stieda syndrome, is a condition characterized by inflammation of the bursa located near the tibial collateral ligament of the knee. This condition can lead to significant discomfort and functional impairment. Below, we explore the clinical presentation, signs, symptoms, and patient characteristics associated with this condition, particularly in relation to the ICD-10 code M76.40.

Clinical Presentation

Overview

Pellegrini-Stieda syndrome typically presents with localized pain and swelling around the knee joint, particularly on the medial side where the tibial collateral ligament is located. The condition may arise due to acute trauma, chronic overuse, or underlying inflammatory processes.

Signs and Symptoms

1. Pain: Patients often report a dull, aching pain on the medial aspect of the knee, which may worsen with activity or prolonged standing.
2. Swelling: There may be noticeable swelling over the affected area, which can be due to fluid accumulation in the bursa.
3. Tenderness: Palpation of the medial knee may elicit tenderness, particularly over the bursa and the tibial collateral ligament.
4. Limited Range of Motion: Patients may experience stiffness and a reduced range of motion in the knee joint, particularly during flexion and extension.
5. Crepitus: Some patients may report a sensation of grinding or popping during knee movement, which can be indicative of underlying joint issues.
6. Warmth and Redness: In cases of acute inflammation, the skin over the affected area may appear warm and reddened.

Patient Characteristics

• Age: Tibial collateral bursitis can occur in individuals of various ages, but it is more commonly seen in middle-aged to older adults due to degenerative changes in the knee joint.
• Activity Level: Patients who engage in activities that place repetitive stress on the knee, such as runners, athletes, or those involved in manual labor, may be at higher risk.
• Previous Injuries: A history of knee injuries or surgeries can predispose individuals to develop bursitis.
• Comorbid Conditions: Conditions such as osteoarthritis, rheumatoid arthritis, or other inflammatory diseases may increase susceptibility to bursitis.

Conclusion

Tibial collateral bursitis (Pellegrini-Stieda syndrome) is characterized by specific clinical signs and symptoms, including localized pain, swelling, and tenderness around the knee. Understanding the patient characteristics and clinical presentation is crucial for accurate diagnosis and effective management. Early intervention can help alleviate symptoms and prevent further complications associated with this condition. If you suspect you or someone you know may be experiencing these symptoms, consulting a healthcare professional for a thorough evaluation and appropriate treatment is recommended.

ICD-10 code M76.40 refers to "Tibial collateral bursitis [Pellegrini-Stieda], unspecified leg." This condition is characterized by inflammation of the bursa located near the tibial collateral ligament, often associated with pain and swelling in the knee area. Below are alternative names and related terms that can be associated with this diagnosis.

Alternative Names

1. Pellegrini-Stieda Syndrome: This term is often used interchangeably with tibial collateral bursitis, highlighting the specific condition characterized by calcification or ossification of the bursa.
2. Tibial Bursitis: A more general term that refers to inflammation of the bursa located near the tibia, which can include the tibial collateral bursa.
3. Knee Bursitis: This term encompasses inflammation of any bursa around the knee joint, including the tibial collateral bursa.
4. Medial Knee Bursitis: Specifically refers to bursitis occurring on the medial (inner) side of the knee, where the tibial collateral ligament is located.

Related Terms

1. Bursitis: A general term for inflammation of a bursa, which can occur in various locations throughout the body.
2. Tendonitis: While not the same, tendonitis can occur in conjunction with bursitis, particularly in the knee region, affecting the tendons around the joint.
3. Ligament Injury: Injuries to the tibial collateral ligament may be related to or cause bursitis in the area.
4. Chronic Pain Syndrome: This broader term may apply if the bursitis leads to ongoing pain and discomfort in the leg.
5. Calcific Bursitis: Refers to the presence of calcium deposits in the bursa, which can occur in chronic cases of bursitis.

Conclusion

Understanding the alternative names and related terms for ICD-10 code M76.40 can aid in better communication among healthcare providers and enhance patient education regarding the condition. If further details or specific inquiries about treatment or management of this condition are needed, feel free to ask!

Tibial collateral bursitis, also known as Pellegrini-Stieda syndrome, is characterized by inflammation of the bursa located near the tibial collateral ligament of the knee. This condition can lead to pain and swelling, particularly on the inner side of the knee. The ICD-10 code M76.40 specifically refers to this condition in an unspecified leg. Here, we will explore standard treatment approaches for managing this condition.

Understanding Tibial Collateral Bursitis

What is Tibial Collateral Bursitis?

Tibial collateral bursitis occurs when the bursa, a small fluid-filled sac that reduces friction between tissues, becomes inflamed. This inflammation can result from repetitive stress, direct trauma, or underlying conditions such as arthritis. Symptoms typically include localized pain, swelling, and tenderness around the knee joint, particularly on the medial side.

Standard Treatment Approaches

1. Conservative Management

Most cases of tibial collateral bursitis can be effectively managed with conservative treatment options:

• Rest: Reducing activities that exacerbate the pain is crucial. Patients are often advised to avoid high-impact sports or activities that put stress on the knee.

• Ice Therapy: Applying ice packs to the affected area for 15-20 minutes several times a day can help reduce swelling and alleviate pain.

• Compression: Using an elastic bandage or knee sleeve can provide support and help minimize swelling.

• Elevation: Keeping the leg elevated can assist in reducing swelling, especially after activities.

2. Medications

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Over-the-counter medications such as ibuprofen or naproxen can help relieve pain and reduce inflammation.

• Corticosteroid Injections: In cases where pain persists despite conservative measures, a healthcare provider may recommend corticosteroid injections directly into the bursa to reduce inflammation.

3. Physical Therapy

Engaging in physical therapy can be beneficial for strengthening the muscles around the knee and improving flexibility. A physical therapist may design a tailored exercise program that includes:

• Stretching Exercises: To improve flexibility in the knee and surrounding muscles.

• Strengthening Exercises: Focusing on the quadriceps, hamstrings, and hip muscles to provide better support to the knee joint.

• Manual Therapy: Techniques such as massage or mobilization may be employed to alleviate pain and improve function.

4. Surgical Intervention

Surgery is rarely required for tibial collateral bursitis but may be considered in chronic cases that do not respond to conservative treatments. Surgical options may include:

• Bursectomy: Removal of the inflamed bursa if it is causing significant pain or functional impairment.

• Repair of Associated Structures: If there are concurrent injuries to ligaments or cartilage, surgical repair may be necessary.

5. Lifestyle Modifications

Patients are often encouraged to make lifestyle changes to prevent recurrence, such as:

• Weight Management: Maintaining a healthy weight can reduce stress on the knee joint.

• Proper Footwear: Wearing supportive shoes can help in reducing knee strain.

• Gradual Return to Activity: After recovery, it is important to gradually reintroduce activities to avoid re-injury.

Conclusion

Tibial collateral bursitis (ICD-10 code M76.40) can be effectively managed through a combination of conservative treatments, medications, physical therapy, and, in rare cases, surgical intervention. Early diagnosis and a tailored treatment plan are essential for optimal recovery and to prevent recurrence. Patients experiencing symptoms should consult a healthcare professional for a comprehensive evaluation and personalized management strategy.

Clinical Description of ICD-10 Code M76.40: Tibial Collateral Bursitis [Pellegrini-Stieda], Unspecified Leg

Overview

ICD-10 code M76.40 refers to tibial collateral bursitis, specifically categorized under the broader term Pellegrini-Stieda syndrome. This condition involves inflammation of the bursa located near the tibial collateral ligament, which is essential for stabilizing the knee joint. The designation "unspecified leg" indicates that the specific leg affected is not identified in the diagnosis.

Etiology

Tibial collateral bursitis can arise from various factors, including:
- Overuse: Repetitive activities, particularly those involving knee flexion and extension, can lead to irritation and inflammation of the bursa.
- Trauma: Direct injury to the knee, such as a fall or impact, may trigger bursitis.
- Underlying Conditions: Conditions like osteoarthritis or rheumatoid arthritis can predispose individuals to bursitis due to joint inflammation.

Symptoms

Patients with tibial collateral bursitis may experience:
- Localized Pain: Pain is typically felt on the inner side of the knee, which may worsen with activity or pressure.
- Swelling: Inflammation can lead to noticeable swelling around the knee joint.
- Stiffness: Patients may report stiffness, particularly after periods of inactivity or upon waking.
- Reduced Range of Motion: The inflammation can limit the knee's mobility, making it difficult to perform certain movements.

Diagnosis

Diagnosis of tibial collateral bursitis generally involves:
- Clinical Examination: A healthcare provider will assess the knee for tenderness, swelling, and range of motion.
- Imaging Studies: X-rays or MRI may be utilized to rule out other conditions and confirm the presence of bursitis.

Treatment

Management of tibial collateral bursitis typically includes:
- Rest and Activity Modification: Reducing activities that exacerbate symptoms is crucial for recovery.
- Physical Therapy: Strengthening and stretching exercises can help restore function and alleviate pain.
- Medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) may be prescribed to reduce pain and inflammation.
- Injections: Corticosteroid injections may be considered for severe cases to provide relief.

Prognosis

The prognosis for tibial collateral bursitis is generally favorable, especially with appropriate treatment. Most patients experience significant improvement with conservative management, although chronic cases may require more intensive interventions.

Conclusion

ICD-10 code M76.40 encapsulates a specific condition that can significantly impact an individual's mobility and quality of life. Understanding the clinical aspects, including symptoms, diagnosis, and treatment options, is essential for effective management and recovery from tibial collateral bursitis. If symptoms persist or worsen, it is advisable to seek further medical evaluation to explore additional treatment avenues.

The diagnosis of Tibial collateral bursitis, also known as Pellegrini-Stieda syndrome, is associated with the ICD-10 code M76.40. This condition typically involves inflammation of the bursa located near the tibial collateral ligament, which can lead to pain and discomfort in the affected leg. Here are the criteria and considerations used for diagnosing this condition:

Clinical Presentation

1. Symptoms: Patients often present with localized pain and swelling around the knee joint, particularly on the medial side where the tibial collateral ligament is located. Pain may worsen with activity or pressure on the area.

2. Physical Examination: A thorough physical examination is crucial. The clinician will assess for tenderness, swelling, and any range of motion limitations in the knee. Specific tests may be performed to evaluate the integrity of the ligaments and the presence of bursitis.

Diagnostic Imaging

1. Ultrasound: This imaging modality can be used to visualize the bursa and assess for fluid accumulation or inflammation. It is non-invasive and can provide real-time images of the soft tissues around the knee.

2. MRI: Magnetic Resonance Imaging is often employed to obtain detailed images of the knee structures, including the bursa, ligaments, and surrounding tissues. MRI can help confirm the diagnosis by showing inflammation or other changes associated with bursitis.

Differential Diagnosis

1. Exclusion of Other Conditions: It is essential to differentiate tibial collateral bursitis from other potential causes of knee pain, such as ligament injuries, meniscal tears, or osteoarthritis. A comprehensive history and physical examination, along with imaging studies, can help rule out these conditions.

2. History of Trauma or Overuse: A history of recent trauma, repetitive stress, or overuse of the knee may support the diagnosis of bursitis. Patients may report activities that exacerbate their symptoms.

Laboratory Tests

While laboratory tests are not typically required for diagnosing tibial collateral bursitis, they may be used to rule out inflammatory or infectious processes if there is suspicion of septic bursitis or other systemic conditions.

Conclusion

In summary, the diagnosis of Tibial collateral bursitis (Pellegrini-Stieda) under ICD-10 code M76.40 involves a combination of clinical evaluation, imaging studies, and exclusion of other knee pathologies. Accurate diagnosis is essential for effective management and treatment of the condition, which may include conservative measures such as rest, ice, compression, elevation (RICE), physical therapy, or, in some cases, corticosteroid injections to reduce inflammation.